Anna Salo Rovira

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders

Vall Hebron Institut de Recerca

Anna Salo Rovira

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders

Vall Hebron Institut de Recerca

Related news

Vall d'Hebron leads the analysis of COVID-19 in rare hematological diseases

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.

Mi Compañero de Viaje adds a decade of donations in the fight against cancer

The association, once again, has shown its commitment to oncological research with a donation of €19,197 to the Cancer and Hematological Diseases Group for Children at VHIR.

Equip del grup de Càncer i Malalties Hematològiques Infantils del VHIR

A study demonstrates the effectiveness of gene therapy in patients with Fanconi anemia

The prestigious journal The Lancet has published the results of this study, which is the result of more than 20 years of pre-clinical research and 7 years of patient follow-up.